Duke Health Center at Southpoint

Durham, North Carolina 27713

0 studies enrolling now · 3 studies all time

What they study most

Cardiomyopathy, Hypertrophic Obstructive, Hypertrophic Cardiomyopathy, Left Ventricular Outflow Tract Obstruction, Medication Therapy Management, Pharmacogenetics

Studies at this site

• A Phase 2 Open-label Pilot Study Evaluating MYK-461 in Subjects With Symptomatic Hypertrophic Cardiomyopathy and Left Ventricular Outflow Tract Obstruction — Completed
• Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy — Stopped early
• Medication Therapy Management With Pharmacogenetic Testing — Completed